Man Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-900
Closed -$365K 2468
2025
Q2
$365K Sell
900
-12,100
-93% -$5.06M ﹤0.01% 1923
2025
Q1
$6.47M Sell
13,000
-16,200
-55% -$8.77M 0.02% 912
2024
Q4
$15.2M Buy
29,200
+14,900
+104% +$8.19M 0.04% 551
2024
Q3
$8.85M Buy
14,300
+4,700
+49% +$2.78M 0.02% 802
2024
Q2
$5.31M Buy
9,600
+6,800
+243% +$3.9M 0.01% 984
2024
Q1
$1.63M Sell
2,800
-1,500
-35% -$842K ﹤0.01% 1384
2023
Q4
$2.28M Buy
+4,300
New +$2.08M 0.01% 1238

Other funds holding TMO

Man Group's TMO Position: Q2 2026 in Review

Man Group increased its Thermo Fisher Scientific (TMO) stake by 321% in Q2 2026, buying an estimated $71.4M and bringing the position to 195,160 shares worth $97.8M. The position accounts for 0.16% of the portfolio, ranked #156.

Man Group first reported a position in TMO in Q1 2018 and has held it in 31 quarters since. The position peaked at $132M in Q3 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Man Group held 195,160 shares of Thermo Fisher Scientific worth $97.8M as of Q2 2026.
  • Man Group bought 148,758 Thermo Fisher Scientific shares in Q2 2026, an estimated $71.4M.
  • Thermo Fisher Scientific made up 0.16% of Man Group's portfolio in Q2 2026, its #156 holding.
  • Man Group first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 31 quarters since.
  • Man Group's Thermo Fisher Scientific position peaked at $132M in Q3 2021.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.